According to the combined score or gene counts, the enriched pathways included pathways in cancer as well as prostate cancer, colorectal cancer, PI3K-Akt, apoptosis, and non-small-cell lung cancer signaling pathways. This evidence concerns the gene AKT1 and prostate carcinoma.